PUBLISHER: IMARC | PRODUCT CODE: 2024844
PUBLISHER: IMARC | PRODUCT CODE: 2024844
The global scientific instrument market size reached USD 48.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 70.2 Billion by 2034, exhibiting a growth rate (CAGR) of 4.13% during 2026-2034. The expanding scientific R&D sector and rising collaboration between the governments and manufacturers to provide the best instruments in government and university laboratories, and various other research institutions are some of the key factors driving the market growth.
Increase in Number of Research and Development Projects
The rising number of research projects & studies is primarily driving the growth of the scientific instruments market. For instance, India's R&D sector is witnessing significant growth, with a notable increase in Gross Expenditure on Research and Development (GERD) from ₹6,01,968 million in 2010-11 to ₹12,73,810 million in 2020-21. In line with this, the United States is the leading country worldwide in terms of spending on research and development (R&D), with expenditures exceeding US$ 760 Billion purchasing power parity (PPP). Additionally, the increasing number of government funded research laboratories across the world is also augmenting the scientific instrument market share. According to the network of national laboratories, there are 69 research institutes/laboratories functioning under the Ministry of Science and Technology in India. Moreover, the rising collaboration between the governments and manufacturers to provide the best instruments in government and university laboratories, and various other research institutions is anticipated to contribute to the market growth across the globe.
Expanding Pharmaceutical and Biotechnology Sectors
Scientific instruments can be used to assist in bringing up novel products that can be used in the therapeutics of various chronic diseases. Moreover, factors such as the rising demand for point-of-care testing, the growing geriatric population, and the high prevalence of target diseases across the globe are expected to augment the need for scientific instruments. For instance, as per the International Diabetes Federation, approximately 537 million adults (20-79 years) were living with diabetes in 2021. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. Hence, the rise in diabetes cases is expected to increase chronic disease complications, thereby driving the demand for scientific instruments to drive in-depth R&D and produce improved therapeutics. Besides this, to combat the rising demand for various biotechnology instruments, several prominent players are taking initiatives, which are positively impacting the scientific instrument market outlook. For instance, in June 2022, Agilent Technologies Inc. publicized that CE-IVD marked instruments, kits, and reagents were released as IVDR Class A in compliance with the new EU IVDR regulation. With the introduction of IVDR-compliant Class A products, labs in the European Union can continue to utilize Agilent IVDR instruments, kits, and reagents in their diagnostic processes without interruption.
Increasing Product Application in the Aerospace Industry
Scientific instruments play a crucial role in aerospace engineering and exploration. Technologies like spectrometers and cameras help analyze the composition of celestial bodies, aiding in planetary exploration and understanding the universe's origins. The rapidly increasing research activities in the aerospace sector are further catalyzing the market for scientific instruments. For instance, the remarkable launch of Chandrayan 3, which took place in August 2023, involved the utilization of various scientific instruments, such as ILSA Seismometer, RAMBHA-LP Langmuir Probe, LRA Retroreflector, CHASTE Thermal Probe, etc. In addition to this, various key market players are increasingly investing in developing technologically advanced instruments to facilitate in depth in the aerospace industry. For instance, in February 2024, Central Scientific Instruments Organization (CSIO) in association with Hindustan Aeronautical Limited (HAL) announced their plan to establish a cutting-edge Centre of Excellence (CoE) for Avionics in Chandigarh for advanced research and development in avionics technology to boost aerospace industry. Such initiatives are anticipated to propel the scientific instrument market size in the coming years.
Industrial users dominate the market, accounting for the largest share
Based on the end-use sectors, the report has segregated the market as industrial, government institutes and academics. According to the scientific instrument market research report, industrial users dominate the market, accounting for the largest share.
Scientific clinical analyzers are the most popular type, holding the majority of the market share
On the basis of type, the market has been segmented into scientific clinical analyzers and scientific analytical instruments. According to the report, scientific clinical analyzers are the most popular type, holding the majority of the market share.
Scientific clinical analyzers are sophisticated laboratory instruments designed to analyze biological samples, such as blood, urine, and tissue, for diagnostic purposes. These analyzers automate the process of testing samples for various parameters like glucose levels, cholesterol levels, and blood cell counts, providing accurate and timely results crucial for medical diagnosis and treatment planning. The scientific instrument market forecast by IMARC indicates that the increasing prevalence of various infectious diseases is prompting manufacturers to introduce advanced scientific instruments for clinical operations. For instance, in March 2022, Thermo Fisher Scientific launched a CE-IVD-marked next-generation sequencing instrument for use in clinical laboratories.
North America currently dominates the global market
On a regional level, the market has been classified into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. According to the report, North America currently dominates the global market.
The growth of the region can be attributed to numerous factors, such as the increasing number of biotechnology research-related activities and the rising prevalence of chronic diseases in North America. For instance, as per the Canadian Cancer Statistics 2022 Special Report, around 233,900 people were diagnosed with cancer in 2022. Also, one in 24 people in Canada was diagnosed with cancer within the previous 25 years. Thus, an increase in chronic diseases like cancer in the North American region is expected to utilize scientific instruments in biotech and pharmaceutical research.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include: